Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This is in large part due to the fact that it is one of the best products in the market today
66 Targeting multiple peptide hormone receptors with the same drug entity appears to be the most promising strategy, where additive, or even synergistic, benefits of simultaneously activating two receptor signalling pathways in bone can be fully realised
Can-Fite BioPharma completed enrollment of the first 247 patients, triggering the pre-specified interim analysis of its pivotal Phase 3 trial (NCT06643260) for piclidenoson, a first-in-class oral A3 adenosine receptor (A3AR) agonist, in moderate-to-severe plaque psoriasis
This lipotropic injection is commonly used in weight management programs to potentially support metabolism and energy levels
US$ 22.63
US$ 25.65
US$ 20.87
US$ 26.53
US$ 22.01
US$ 24.43
